Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
IDNAvsGNOMETF Comparison
iShares Genomics Immunology and Healthcare ETF (IDNA) and Global X Genomics & Biotechnology ETF - USD (GNOM) belong to the same industry segment: BioTech & Genomics. Both ETFs have the same top 3 sector exposures: and Health Care. IDNA is less expensive with a Total Expense Ratio (TER) of 0.47%, versus 0.5% for GNOM. IDNA is up 14% year-to-date (YTD) with +$5M in YTD flows. GNOM performs worse with -0.99% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of IDNA and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
IDNA vs GNOM performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IDNA GNOM | +2.96%-2.35% | +12.62%-3.29% | +14.00%-0.99% | +39.25%+29.80% | +33.46%-6.02% | -34.44%-51.80% |
| Flows | IDNA GNOM | +$5M- | +$5M-$4M | +$5M-$2M | +$293K-$19M | -$22M-$115M | -$964K+$11M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IDNA GNOM | +22.83%+23.45% | +25.56%+30.08% | +24.01%+28.53% | +28.14%+33.47% |
| Max drawdown | IDNA GNOM | -6.17%-10.89% | -18.64%-22.14% | -30.61%-46.50% | -68.19%-72.17% |
| Max drawdown duration | IDNA GNOM | 29d48d | 127d113d | 279d1031d | 1634d1714d |
IDNA | GNOM | |
Last sale 3/12/2026 at 1:30 PM | $28.91 | $43.61 |
| Previous close 03/11/2026 | $29.96 | $45.00 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IDNA | GNOM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IDNA | GNOM | |
|---|---|---|
| Last price | $28.91 | $43.61 |
| 1D performance | -3.50% | -3.09% |
| AuM | $153.72 M | $49.36 M |
| E/R | 0.47% | 0.5% |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the IDNA and GNOM ETFs performed in 2026?
As of March 11, 2026, IDNA is up 14% year-to-date (YTD), while GNOM has lost -0.99%. That puts IDNA better performer ahead so far this year.
Which ETF is attracting more investor money: IDNA or GNOM?
Year-to-date, the IDNA ETF saw +$5M in flows, compared to -$2M for GNOM.
Which ETF is more volatile: IDNA or GNOM?
Over the past year, IDNA had a volatility of 25.56%, while GNOM experienced 30.08%.
Which ETF is bigger: IDNA or GNOM?
As of March 11, 2026, IDNA holds $153.72 M in assets under management (AUM), while GNOM manages $49.36 M.
What sectors do the IDNA and GNOM ETFs invest in?
IDNA leans toward sectors like Health Care. Meanwhile, GNOM focuses on Health Care.
What are the top holdings of the IDNA ETF and GNOM ETF?
IDNA top holdings include MODERNA INC, BAYER AG and REVOLUTION MEDICINES INC. GNOM holds in its top three: MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070.
Which ETF is more diversified: IDNA or GNOM?
IDNA holds 51 securities with 62.44% of its assets in the top 15. GNOM has 48 securities and a top 15 weight of 63.95%.
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
